Today (20 December), the European Commission has granted a conditional marketing authorization (CMA) for the COVID‑19 vaccine Nuvaxovid, developed by Novavax, the fifth COVID-19 vaccine authorized...
Good afternoon, health colleagues, and welcome to the European Alliance for Personalised Medicine (EAPM) update. 2021 has been a very busy year for EAPM, with much...
Ahead of the European Council on 16-17 December where EU leaders will discuss the spread of new COVID19 variant Omicron and the preparations for a crucial...
The EU must continue its concerted efforts to fight the COVID-19 pandemic and take urgent measures to ramp up vaccines production to meet citizens’ expectations, MEPs...
France is contemplating tightening controls for travellers coming from Britain, where the new, more contagious, Omicron coronavirus variant seems to be rapidly spreading, said French government...
Parliament’s Special Committee on Beating Cancer adopted its final proposals on how to strengthen the EU’s role in the fight against cancer. In the report adopted...
The Regulation on Health Technology Assessment (HTA), a deliverable of the EU Pharmaceutical Strategy, has been adopted. The new rules will allow vital and innovative health...